Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._1 type RangedSequencePosition NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc.assertion.
- NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._1 type SO_0001148 NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc.assertion.
- NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._1 comment "Reduces binding to AP1S2 by 33%. Greatly reduced binding to GRB2. Reduced endocytosis by 50%. Reduced endocytosis by 77%; when associated with N-1203." NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc.assertion.
- NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._1 SIO_000053 NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._2 NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc.assertion.
- NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._1 SIO_000053 NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc._3 NX_P15941-7_MUTAGEN_243_243.RA3fHcp01GtqRZYnJw2V2PBcqnDqX0MfH3Rx9I9PVHYKc.assertion.